Indacaterol provides 24-hour bronchodilation in COPD: a placebo-controlled blinded comparison with tiotropium

BACKGROUND: Indacaterol is a novel, inhaled, once-daily, ultra-long-acting β(2)-agonist for the treatment of chronic obstructive pulmonary disease (COPD). This randomized, double-blind study compared the bronchodilator efficacy of indacaterol with that of placebo and tiotropium in patients with mode...

Full description

Saved in:
Bibliographic Details
Main Authors: Vogelmeier, Claus, Ramos-Barbon, David, Jack, Damon, Piggott, Simon, Owen, Roger, Higgins, Mark, Kramer, Benjamin
Format: Artigo
Language:Inglês
Published: BioMed Central 2010
Subjects:
Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2964613/
https://ncbi.nlm.nih.gov/pubmed/20920365
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1465-9921-11-135
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items